Pharmaceutically active carotenoids
US6218436A · kind A · utility
58Cited by
5References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 1996 |
| Grant date | Apr 17, 2001 |
| Priority date | — |
| Expiry date | Dec 23, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The carotenoids lutein and zeaxanthin are disclosed for pharmaceutical use in the treatment of advanced macular degeneration. High dosages are deployed to produce the high serum carotenoid levels needed to cause take-up by the macula.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.